Latest Market Strategy News

SOCO Corporation Ltd has posted a preliminary 18% increase in first-half FY2025 revenue to $11 million, yet project delays and reduced federal government demand temper full-year growth expectations.

ImpediMed Limited has locked in a US$15 million growth capital facility with SWK Funding LLC, providing crucial financial flexibility to advance its SOZO Digital Health Platform and commercial ambitions.

PEXA Group Limited announced the resignation of its Australian CEO, Les Vance, effective February 21, 2025, marking a significant leadership change for the digital property exchange giant.

Wellnex Life has secured Therapeutic Goods Administration approval for its Liquid Paracetamol plus Caffeine Soft Gel, marking its fourth market authorisation and opening new revenue avenues.

Beamtree Holdings appoints Marek Stepniak as CEO, signaling a strategic push in international markets with a strong leadership hand familiar with the company’s growth trajectory.

Atomos Limited reported a 7% increase in Q2 FY25 sales driven by its core Shinobi II product, but faced margin pressures due to discounting and competitive pricing. The company is finalizing a cost restructure and reviewing funding options to support future growth.

AdNeo reported a standout quarter with record new sales led by its US-based Art of Mentoring division and significant operational cost reductions, positioning the company for growth through strategic acquisitions.

Alexium International Group reports a 16% sales increase in Q2 FY25 despite ongoing mattress market softness, driven by strategic product diversification and supply chain improvements.

Adslot Ltd reports a robust Q2 FY25 with significant contract wins for its StoreFront platform and a 43% quarter-on-quarter increase in monetised transaction value, despite ongoing challenges in the Australian market.

Fluence Corporation delivered a standout Q4 2024 with revenue more than doubling prior quarters, overcoming project delays and market headwinds to set the stage for robust growth in 2025.

ImpediMed Limited has reported record quarterly revenue and cash receipts for Q2 FY25, alongside significant growth in reimbursement coverage and a robust sales pipeline, signaling strong momentum in its digital health platform business.

HITIQ Limited has extended its Premier League partnership by 18 months with a 60% contract value increase, appointed a new Chief Marketing Officer, and raised an additional $3 million to accelerate global growth.